Ciuta S T, Boros S, Napoli P A, Pezzotti P, Rezza G
Istituto Superiore di Sanitá, Laboratory of Epidemiology and Biostatistics, Centro Operativo AIDS, Rome, Italy.
AIDS Patient Care STDS. 1998 Aug;12(8):629-37. doi: 10.1089/apc.1998.12.629.
To evaluate length and predictors of survival among children with AIDS, 529 pediatric cases diagnosed in Italy from 1983 to August 1995 were reviewed. Data were analyzed using Kaplan-Meier curves and the Cox proportional hazards regression model. Various survival patterns were subsequently analyzed. All survival analyses were truncated on March 1, 1996. Cases were examined by gender, age at diagnosis, HIV transmission category, type and number of the first AIDS-defining diseases, level of immunosuppression at AIDS diagnosis, HIV transmission category of the mother, and period of diagnosis. The overall median survival time was approximately 24 months. There wer no significant differences in survival by gender, HIV transmission category, mother's risk factor, or period of diagnosis. The Kaplan-Meier analysis showed the greatest differences in survival time between children less than 6 months of age at diagnosis (median survival 6.4 months) and all others (median 28.7 months). Children with recurrent bacterial infections or lymphoid interstitial pneumonia (LIP) had a survival time at least four times longer than those with Pneumocystis carinii pneumonia (PCP), mycobacteriosis, cytomegalovirus, tumors, or progressive multifocal leukoencephalopathy. At the multivariate analysis, the risk of death was lower among children with LIP (Relative Hazard [RH] 0.72) compared with other opportunistic diseases, whereas age less than 6 months, diagnosis of PCP or of two or more diseases, and severe immunosuppression at diagnosis increased the risk of death. Both demographic factors (age) and clinical factors (type and number of initial diseases, level of immunosuppression) were found to be independent predictors of a poor prognosis in children with AIDS. This information may be of use in improving prognosis and planning healthcare and treatment.
为评估艾滋病患儿的生存时长及生存预测因素,我们回顾了1983年至1995年8月在意大利诊断出的529例儿科病例。使用Kaplan-Meier曲线和Cox比例风险回归模型对数据进行分析。随后分析了各种生存模式。所有生存分析均于1996年3月1日截断。按照性别、诊断时年龄、HIV传播类别、首例艾滋病定义疾病的类型和数量、艾滋病诊断时的免疫抑制水平、母亲的HIV传播类别以及诊断时期对病例进行检查。总体中位生存时间约为24个月。在生存方面,性别、HIV传播类别、母亲的风险因素或诊断时期并无显著差异。Kaplan-Meier分析显示诊断时年龄小于6个月的儿童(中位生存时间6.4个月)与其他所有儿童(中位生存时间28.7个月)在生存时间上差异最大。患有复发性细菌感染或淋巴样间质性肺炎(LIP)的儿童的生存时间至少是患有卡氏肺孢子虫肺炎(PCP)、分枝杆菌病、巨细胞病毒、肿瘤或进行性多灶性白质脑病儿童的四倍。在多变量分析中,与其他机会性疾病相比,患有LIP的儿童死亡风险较低(相对风险[RH] 0.72),而年龄小于6个月、诊断为PCP或两种或更多种疾病以及诊断时严重免疫抑制会增加死亡风险。人口统计学因素(年龄)和临床因素(初始疾病的类型和数量、免疫抑制水平)均被发现是艾滋病患儿预后不良的独立预测因素。这些信息可能有助于改善预后以及规划医疗保健和治疗。